Cosmo Bio Company,Limited (3386.T)
JPY 1169.0
(0.6%)
JPY 1169.0
(0.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 442 Million JPY | -14.51% |
| 2022 | 517 Million JPY | -29.85% |
| 2021 | 737 Million JPY | 9.35% |
| 2020 | 674 Million JPY | 184.39% |
| 2019 | 237 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 230 Million JPY | 202.63% |
| 2024 Q2 | 28 Million JPY | -87.83% |
| 2023 Q1 | 264 Million JPY | 319.05% |
| 2023 Q3 | 5 Million JPY | -94.85% |
| 2023 FY | 442 Million JPY | -14.51% |
| 2023 Q4 | 76 Million JPY | 1420.0% |
| 2023 Q2 | 97 Million JPY | -63.26% |
| 2022 Q3 | 46 Million JPY | 0.0% |
| 2022 FY | 517 Million JPY | -29.85% |
| 2022 Q4 | 63 Million JPY | 36.96% |
| 2021 FY | 737 Million JPY | 9.35% |
| 2020 FY | 674 Million JPY | 184.39% |
| 2019 FY | 237 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 5.53 Billion JPY | 92.009% |
| DNA Chip Research Inc. | -248.29 Million JPY | 278.015% |
| H.U. Group Holdings, Inc. | -7.55 Billion JPY | 105.852% |
| FALCO HOLDINGS Co., Ltd. | 1.66 Billion JPY | 73.469% |
| BML, Inc. | 6.03 Billion JPY | 92.675% |
| Human Metabolome Technologies, Inc. | 243.24 Million JPY | -81.708% |
| Precision System Science Co., Ltd. | -1.12 Billion JPY | 139.412% |